Insights On Partnering

  1. Clinical Trials Laboratories In The Immuno-Oncology Setting
    6/25/2018

    The development of immuno-oncology (I/O) medicines offer a new era of treatment options for physicians and patients. However, the level of sophistication required for biomarker selection, trial design, technology implementation, testing, and commercialization planning is unprecedented. Learn more about how clinical trial laboratories are utilizing multiple technologies and solutions to support immuno-oncology clinical development.

  2. Using Gene Signature Methodologies To Strengthen Immuno-Oncology Trials
    6/25/2018

    Cutting edge genomics technologies to power and enhance immuno-oncology (IO) trials where reporting transcriptional response pairs a person to therapy without multiple biopsies.

  3. Microsatellite Instability Assay For Response To Immunotherapy
    6/22/2018

    MSI assay for sensitive detection of 5 mononucleotide repeat markers in tumor FFPE specimens.

  4. Immune Landscape Signatures For Characterization Of Tumor Microenvironment And Response To Therapy
    6/22/2018

    Gene expression and analysis for detection of 11 Immune Landscape Signatures.

  5. A Proactive Approach To Ebola Vaccine Development
    6/21/2018

    Best practices for rapid test development and regulatory approvals.

  6. Fighting Cancer: Biomarkers For Immuno-Oncology Clinical Trials
    6/21/2018

    Using anatomic pathology for biomarker development in clinical trials can help predict and assess how a patient will respond to immuno-oncology therapies

  7. Minimal Residual Disease: Finding The Right Test For The New Definition Of Remission
    6/21/2018

    Measurement of Residual Disease for improved oncology trial outcomes - what factors make an MRD test most effective plus explore the pros and cons of various MRD measurement approaches.

  8. Planning And Implementing Biomarker Testing For immuno-Oncology Trials
    6/14/2018

    Exploring the challenges with the diverse clinical biomarker requirements.

  9. Immunotherapy And PD-L1: The Future Of Precision Medicine
    6/14/2018

    Advances in precision medicine lead to new trends in immunotherapy.

  10. Using Advanced Techniques For Protein Bioanalysis
    6/14/2018

    Overcoming hurdles in a regulated setting.